Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 4, 2012Transfusion

Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura

View Full Paper
Ask AI
Bookmark
Share

Authors

VBVinai BhagirathPopulation Health Research InstituteJKJohn G. KeltonMcMaster University Medical CentreJMJane C. MooreMcMaster University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bhagirath et al. (2012) studied this question.

synapsesocial.com/papers/6aaa2f401a5deadb6735f59ehttps://doi.org/10.1111/j.1537-2995.2012.03635.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic Purpura1991 · 1,940 citations
  2. 2A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis2011 · 406 citations
  3. 3Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab2011 · 298 citations
  4. 4von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome1998 · 1,674 citations
  5. 5Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies2009 · 90 citations